TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ZENRELIA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ZENRELIA

ST13

US500000079367703

Classe

5

Pedido

79367703

Registro

7483952

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

08/03/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

07/03/2023

Data de registro

27/08/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/08/2024

Última transação

08/03/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

MIZELLE HOWARD, DEZMONA

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Elanco UK AH Limited

Representantes

Jeannine Rittenhouse IpHorgan Ltd.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment, diagnosis, prevention and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; animal feed additives for use as nutritional supplements; veterinary preparations or animal feed additives for use in decreasing gas emissions from animals, animal carcasses, or animal waste; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely, to treat and prevent parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control and prevention of reproductive functions; veterinary preparations for treating and preventing fleas, ticks, lice, flies, and mosquitos on companion animals; veterinary preparations, namely, vaccines for companion animals including horses; veterinary preparations to control diseases and parasites in fish

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/03/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

16/02/2025

FIMP

FINAL DISPOSITION PROCESSED

15/02/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

27/11/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/08/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

27/08/2024

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

21/07/2024

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

02/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2024

GPNX

NOTIFICATION PROCESSED BY IB

12/03/2024

PUBO

PUBLISHED FOR OPPOSITION

12/03/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

21/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/02/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

21/02/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/01/2024

RFNT

REFUSAL PROCESSED BY IB

08/01/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/12/2023

RFRR

REFUSAL PROCESSED BY MPU

19/12/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

13/12/2023

CNRT

NON-FINAL ACTION WRITTEN

12/12/2023

DOCK

ASSIGNED TO EXAMINER

05/12/2023

MAFR

APPLICATION FILING RECEIPT MAILED

21/04/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/04/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

14/04/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ZENRELIA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.